BMO Capital Downgrades Covidien Ltd (COV) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- S&P 500, Dow set for lower open after jobs report fuels rate-hike bets
- US nonfarm payrolls surge in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil heads for weekly gain as US-Iran fighting resumes; diesel hits record high
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Barclays Downgrades Covidien Ltd (COV) to Equalweight
June 18, 2014 7:13 AM EDTBarclays downgraded Covidien Ltd (NYSE: COV) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Covidien Ltd click here. For more ratings news on Covidien Ltd click here.
Shares of Covidien Ltd closed at $88.12 yesterday.
... MoreNeedham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal
June 16, 2014 7:30 AM EDTNeedham & Company analyst Mike Matson comments on the sector implications amid Medtronic's (NYSE: MDT) $42.9 billion deal to acquire Covidien (NYSE: COV).
The analyst said while the media is likely to focus on the tax inversion angle, which is certainly playing a role, they... More
William Blair Downgrades Covidien Ltd (COV) to Market Perform
June 16, 2014 7:18 AM EDTWilliam Blair downgraded Covidien Ltd (NYSE: COV) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Covidien Ltd click here. For more ratings news on Covidien Ltd click here.
Shares of Covidien Ltd closed at $72.02 yesterday.
... MoreUPDATE: JPMorgan Upgrades Medtronic, Inc. (MDT) to Overweight
June 16, 2014 6:59 AM EDT(Updated - June 16, 2014 11:35 AM EDT)
JPMorgan upgraded Medtronic, Inc. (NYSE: MDT) from Neutral to Overweight with a price target of $78.00 (from $64.00). The upgrade follows Medtronics agreement to acquire Covidien (NYSE: COV).
Analyst Michael... More
Medtronic (MDT) to Acquire Covidien (COV) in $42.9B Deal
June 16, 2014 6:12 AM EDTMedtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, and Covidien plc (NYSE: COV), a global healthcare technology and medical supplies provider, today announced that they have entered into a definitive agreement under which Medtronic has agreed to acquire Covidien in a cash-and-stock transaction valued at $93.22 per Covidien share, or a total of approximately $42.9 billion, based on Medtronic`s closing stock price of $60.70 per share on June 13, 2014.
Once the transaction is completed, Medtronic will have significantly advanced its position as the world`s premier... More
Medtronic (MDT) in Advanced Talks to Acquire Covidien (COV) - WSJ
June 14, 2014 12:20 PM EDTMedtronic (NYSE: MDT) is in advanced talks to acquire Covidien (NYSE: COV) for more than $40 billion, the Wall Street Journal reported Saturday citing people familiar with the matter. The deal price suggests a premium of at... More
